| Literature DB >> 36176347 |
Lingying Jia1, Yan Hu1.
Abstract
Objective: This study aims to describe the experience and connotations of self-management about adjuvant therapy (AT) in Chinese breast cancer survivors (BCS) and explore possible factors that affect their self-management level.Entities:
Keywords: adjuvant therapy; breast neoplasm; self-management; survivorship
Year: 2022 PMID: 36176347 PMCID: PMC9514877 DOI: 10.2147/PPA.S379435
Source DB: PubMed Journal: Patient Prefer Adherence ISSN: 1177-889X Impact factor: 2.314
Basic Information of Experts Involved in the Concept Demonstration (n=15)
| No. | Education Level | Professional Title | Work Seniority (Year) | Work Place | Directions |
|---|---|---|---|---|---|
| V1 | M.D. | Attending physician | 12 | Hospital | Comprehensive treatment of breast cancer |
| V2 | Ph.D | Professor | 17 | College | Clinical nursing; Community care |
| V3 | Ph.D | Associate Professor | 11 | College | Clinical nursing; Nursing education |
| V4 | Ph.D | Professor of nursing | 30 | Hospital | Nursing management; Oncology |
| V5 | Ph.D | Research fellow | 3 | College | Nursing research; Oncology |
| V6 | Ph.D | Associate Professor | 30 | College | Nursing education; Community care |
| V7 | Ph.D | Research fellow | 11 | College | Nursing research; Oncology |
| V8 | Ph.D | Associate Professor | 21 | College | Nursing education; Psychological nursing |
| V9 | Ph.D | Research fellow | 2 | College | Nursing research; Oncology |
| V10 | Ph.D | Professor | 30 | College | Clinical nursing; Nursing education |
| V11 | Ph.D | Associate Professor of nursing | 15 | Hospital | Nursing education; Oncology |
| V12 | M.Sc | Associate Professor of nursing | 14 | Hospital | Nursing management; Oncology |
| V13 | B.S. | Nurse-in-charge | 15 | Hospital | Clinical nursing; Oncology |
| V14 | M.Sc | Nurse-in-charge | 7 | Hospital | Clinical nursing; Oncology |
| V15 | Ph.D | Professor of nursing | 25 | Hospital | Nursing management; Oncology |
Demographic Data (n=29)
| No. | Age | Education Level | Caregivers | TNM Stage | Molecular Subtyping | Surgery Type | Chemotherapy Regimensa | Chemotherapy Periods | Targeted Drugsb | Targeted Therapy Number (Times) | Radiotherapy Number (Times) | Endocrine Drugs | Endocrine Therapy Length (Months) | Employment Status | Marital Status | Economic Burden | Knowledge of the Cancer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A1 | 34 | Bachelor or above | Parents | T2N3M0 | Basal-like | Modified radical mastectomy | ddEC-T | 8 | / | 0 | 0 | / | 0 | Full-time | Married | No | Basically |
| A2 | 59 | Technical secondary school/High school | Children | T2N0M0 | Luminal B | Modified radical mastectomy | TC | 6 | / | 0 | 0 | Toremifene | 80 | Retired | Married | No | Basically |
| A3 | 73 | Junior college | Children | T2N1M0 | Luminal B | Breast conserving surgery | / | 0 | / | 0 | 30 | Exemestane | 3 | Retired | Married | No | Little |
| A4 | 46 | Bachelor or above | Spouse | T2N1M0 | Luminal B | Modified radical mastectomy | EC*4-TC*4 | 8 | / | 0 | 0 | Toremifene | 28 | Full-time | Married | Light | Basically |
| A5 | 51 | Technical secondary school/High school | Spouse | T1N0M0 | Luminal B | Extended radical mastectomy | TC | 4 | H | 17 | 15 | Tamoxifen | 15 | Retired | Married | No | Basically |
| A6 | 53 | Junior college | Spouse | T1N0M0 | Luminal B | Simple mastectomy | TC | 4 | / | 0 | 0 | Tamoxifen | 28 | Full-time | Married | No | Basically |
| A7 | 40 | Bachelor or above | Parents | T2N1M0 | Luminal B | Modified radical mastectomy | TC | 6 | / | 0 | 16 | Toremifene | 6 | No job | Single | Heavy | Partly |
| A8 | 42 | Junior high school | Spouse | T1N0M0 | Luminal B | Breast conserving surgery | / | 0 | / | 0 | 15 | Toremifene | 8 | Part-time | Married | Light | Partly |
| A9 | 44 | Bachelor or above | Spouse | T2N1M0 | Luminal B | Breast conserving surgery | TC | 4 | H | 18 | 30 | Tamoxifen | 19 | Full-time | Married | No | Basically |
| A10 | 46 | Bachelor or above | / | T1N0M0 | Luminal B | Simple mastectomy | / | 0 | / | 0 | 0 | Toremifene | 15 | Full-time | Married | Light | Basically |
| A11 | 66 | Technical secondary school/High school | Spouse | T1N0M0 | Luminal A | Breast conserving surgery | / | 0 | / | 0 | 0 | Anastrozole | 26 | Retired | Married | No | Basically |
| A12 | 68 | Bachelor or above | Spouse | T1N0M0 | Luminal B | Modified radical mastectomy | EC*4-T*4 | 8 | / | 0 | 25 | Anastrozole | 57 | Retired | Married | Light | Basically |
| A13 | 57 | Technical secondary school/High school | / | T1N0M0 | Luminal B | Simple mastectomy | / | 0 | / | 0 | 0 | Toremifene | 40 | Retired | Married | No | Little |
| A14 | 40 | Bachelor or above | / | T1N0M0 | Luminal B | Breast conserving surgery | EC*4-wP*10 | 14 | / | 0 | 25 | Tamoxifen | 63 | Full-time | Married | No | Very well |
| A15 | 63 | Technical secondary school/High school | Spouse | T1N0M0 | Luminal A | Simple mastectomy | / | 0 | / | 0 | 0 | Letrozole | 42 | Retired | Married | Light | Partly |
| A16 | 49 | Junior college | / | T2N0M0 | Luminal B | Breast conserving surgery | AC*4-T*4 | 8 | H | 17 | 30 | Anastrozole | 24 | No job | Divorced | Heavy | Basically |
| A17 | 42 | Bachelor or above | Parents | T1N1M0 | Luminal B | Modified radical mastectomy | ddEC-T | 8 | / | 0 | 25 | Exemestane | 36 | Full-time | Divorced | No | Basically |
| A18 | 48 | Junior high school | Spouse | T1N1M0 | Luminal B | Modified radical mastectomy | EC*4-T*4 | 8 | / | 0 | 25 | Exemestane | 43 | No job | Married | No | Little |
| A19 | 73 | Technical secondary school/High school | Children | T1N0M0 | Luminal B | Simple mastectomy | / | 0 | / | 0 | 0 | Anastrozole | 58 | Retired | Married | No | Partly |
| A20 | 48 | Junior college | / | T1N0M0 | Luminal B | Breast conserving surgery | / | 0 | H | 10 | 15 | Toremifene | 8 | Full-time | Married | No | Basically |
| A21 | 49 | Junior high school | Spouse | T3N3M0 | HER-2 Enriched | Modified radical mastectomy | PC | 6 | HP | 4 | 0 | / | 0 | Retired | Married | Heavy | Basically |
| A22 | 57 | Bachelor or above | / | T1N0M0 | HER-2 Enriched | Simple mastectomy | TC | 4 | H | 10 | 0 | / | 0 | Retired | Married | No | Basically |
| A23 | 33 | Bachelor or above | Parents | T1N1M0 | HER-2 Enriched | Modified radical mastectomy | wP | 4 | H | 5 | 0 | Tamoxifen | 2 | Full-time | Married | Light | Basically |
| A24 | 55 | Technical secondary school/High school | Spouse | T1N3M0 | HER-2 Enriched | Breast conserving surgery | PC | 6 | HP | 5 | 13 | / | 0 | Retired | Married | Heavy | Basically |
| A25 | 56 | Bachelor or above | Spouse | T1N0M0 | HER-2 Enriched | Modified radical mastectomy | AC*6-T*4 | 10 | HP | 10 | 0 | / | 0 | Retired | Married | Heavy | Little |
| A26 | 36 | Bachelor or above | Parents | T2N2M0 | HER-2 Enriched | Modified radical mastectomy | PC | 6 | HP | 7 | 19 | / | 0 | Full-time | Married | Moderate | Basically |
| A27 | 45 | Primary or below | Spouse | T2N1M0 | HER-2 Enriched | Modified radical mastectomy | PC | 6 | HP | 17 | 25 | / | 0 | No job | Married | Heavy | Little |
| A28 | 54 | Primary or below | Spouse | T2N1M1 | Luminal B | Modified radical mastectomy | AC*4-T*4 | 8 | / | 0 | 0 | Letrozole | 22 | No job | Married | Heavy | Little |
| A29 | 39 | Technical secondary school/High school | Spouse | T2N1M1 | Basal-like | Breast conserving surgery | TAC*4-NP*2 | 6 | / | 0 | 15 | / | 0 | No job | Married | Light | Basically |
Abbreviations: aChemotherapy Regimens: TC, Taxotere+Cyclophosphamide; PC, Paclitaxel+Carboplatin; EC, Epirubicin+Cyclophosphamide; EC-T, Epirubicin+Cyclophosphamide-sequential Taxotere; EC-P, Epirubicin+Cyclophosphamide-sequential Paclitaxel; AC-T, Adriamycin+Cyclophosphamide -Taxotere; wP, weekly Paclitaxel(Taxol); TAC-NP, Paclitaxel+Anthracycline+Cyclophosphamide -Navelbine+Cisplatin; bTargeted drugs: H, Trastuzumab; P, Pertuzumab.
Figure 1The conceptual structure of self-management about adjuvant therapy in breast cancer survivors.
The Connotation of Self-Management About Adjuvant Therapy in Breast Cancer Survivors
| Themes | Subcategories | Connotations |
|---|---|---|
| Medical related management | AT-related adverse reactions | The ability of Breast Cancer Survivors(BCS) to identify, self-monitor and cope with adverse reactions of treatments during adjuvant therapy (AT). |
| Medical cooperation and knowledge acquisition | The ability to communicate and cooperate with medical staff, participate in medical decision-making, obtain information through medical staff or other potential support systems (such as patients, friends, family, etc.), filter and internalize information. | |
| Recovery and protection of affected limb | The ability of BCS to follow the professional advice to protect affected limb, also to prevent, identify and cope with breast cancer related lymphedema (BCRL), axillary web syndrome (AWS) and dysfunction. Remedies include functional exercise, massage, wearing therapeutic elastic sleeve or bandage etc. | |
| Medical compliance | The ability of BCS to complete medical examinations and treatments (including buying, managing, and using oral drugs or medical supplies) according to medical advice during AT. | |
| Body image | The ability of BCS to accept or to cope with image changes such as breast loss, surgical scarring, hair loss and skin pigmentation during AT. | |
| Sexual function and fertility | The ability of BCS who have the needs to seek support and to follow the advice for fertility preservation or restoration of sexual function. | |
| Healthy lifestyle | The ability of BCS to improve nutritional status (e.g.weight), symptom experience (e.g.fatigue), and physical indicators (e.g.blood lipid, blood glucose) by adjusting and maintaining lifestyles such as diet, sleep schedule, and exercise. | |
| Catheter daily protection (for patients under chemical or targeted therapy) | The ability to protect catheters in daily life scenario, to recognize abnormality, and to regularly go for catheter maintenance during adjuvant chemotherapy and targeted therapy. | |
| AT-related financial burdens | The ability of BCS to avoid or mitigate AT-related financial burden by means of medical insurance, public assistance, loan, return to work (RTW), change consumption habits, adjust therapeutic regimens (by participating in clinical trial, reducing out-of-pocket payments, etc.) | |
| Emotion management | Recognition of negative emotions | The ability to perceive negative emotions such as anxiety, sadness, low self-esteem, psychological pain, fear of relapse etc. |
| Prevention of negative emotions | The ability to self-regulate or modify before negative emotions occur, which include situation selection, situation modification, attentional deployment, cognitive change, reappraisal, etc. | |
| Regulation of emotional responses | The ability to self-control or self-regulate the emotional responses after negative emotions occur, which include seeking professional support, expressive suppression, emotional catharsis, etc. | |
| Role management | Family role management | The ability of BCS to adapt to diminished or adjusted family role functions due to AT and to maintain or restore meaningful family involvement. |
| Social role management | The ability of BCS to adapt to diminished or adjusted social role functions due to AT and to maintain or restore meaningful social engagement. | |
| Work role management | The ability of BCS to adapt to diminished or adjusted work role functions due to AT and to maintain or restore meaningful work engagement. |